These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 20160715)
1. Changes in liver biochemistry during methotrexate use for inflammatory bowel disease. Fournier MR; Klein J; Minuk GY; Bernstein CN Am J Gastroenterol; 2010 Jul; 105(7):1620-6. PubMed ID: 20160715 [TBL] [Abstract][Full Text] [Related]
2. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Te HS; Schiano TD; Kuan SF; Hanauer SB; Conjeevaram HS; Baker AL Am J Gastroenterol; 2000 Nov; 95(11):3150-6. PubMed ID: 11095334 [TBL] [Abstract][Full Text] [Related]
3. Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials. Khan N; Abbas AM; Whang N; Balart LA; Bazzano LA; Kelly TN Inflamm Bowel Dis; 2012 Feb; 18(2):359-67. PubMed ID: 21751301 [TBL] [Abstract][Full Text] [Related]
4. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent. Berends MA; Snoek J; de Jong EM; van de Kerkhof PC; van Oijen MG; van Krieken JH; Drenth JP Aliment Pharmacol Ther; 2006 Sep; 24(5):805-11. PubMed ID: 16918884 [TBL] [Abstract][Full Text] [Related]
5. [Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?]. Nieminen U; Höök-Nikanne J; Kärkkäinen P; Niemelä S Duodecim; 2005; 121(24):2680-8. PubMed ID: 16454249 [No Abstract] [Full Text] [Related]
6. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients. Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043 [TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate. Amital H; Arnson Y; Chodick G; Shalev V Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136 [TBL] [Abstract][Full Text] [Related]
8. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis. Szanto E; Sandstedt B; Kollberg B Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206 [TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity caused by methotrexate therapy in children with inflammatory bowel disease: a systematic review and meta-analysis. Valentino PL; Church PC; Shah PS; Beyene J; Griffiths AM; Feldman BM; Kamath BM Inflamm Bowel Dis; 2014 Jan; 20(1):47-59. PubMed ID: 24280876 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience. González-Lama Y; Taxonera C; López-Sanromán A; Pérez-Calle JL; Bermejo F; Pajares R; McNicholl AG; Opio V; Mendoza JL; López P; Algaba A; Estelles J; Barbero A; Mendoza J; Maté J; Gisbert JP; Eur J Gastroenterol Hepatol; 2012 Sep; 24(9):1086-91. PubMed ID: 22713509 [TBL] [Abstract][Full Text] [Related]
11. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients. vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673 [TBL] [Abstract][Full Text] [Related]
15. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified? Aithal GP; Haugk B; Das S; Card T; Burt AD; Record CO Aliment Pharmacol Ther; 2004 Feb; 19(4):391-9. PubMed ID: 14871278 [TBL] [Abstract][Full Text] [Related]
16. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen. Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813 [TBL] [Abstract][Full Text] [Related]
17. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Whiting-O'Keefe QE; Fye KH; Sack KD Am J Med; 1991 Jun; 90(6):711-6. PubMed ID: 1828327 [TBL] [Abstract][Full Text] [Related]
18. Transient increase of aminotransferases in RA patients treated with methotrexate. Lacki JK; Samborski W; Machiewicz SH Z Rheumatol; 1993; 52(4):232-5. PubMed ID: 8212923 [TBL] [Abstract][Full Text] [Related]
19. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis. Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546 [TBL] [Abstract][Full Text] [Related]
20. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. Hashkes PJ; Balistreri WF; Bove KE; Ballard ET; Passo MH J Pediatr; 1999 Jan; 134(1):47-52. PubMed ID: 9880448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]